Jared C. Foster

2.0k total citations
27 papers, 928 citations indexed

About

Jared C. Foster is a scholar working on Oncology, Statistics and Probability and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jared C. Foster has authored 27 papers receiving a total of 928 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Statistics and Probability and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jared C. Foster's work include Statistical Methods in Clinical Trials (7 papers), Advanced Causal Inference Techniques (4 papers) and Cancer Genomics and Diagnostics (4 papers). Jared C. Foster is often cited by papers focused on Statistical Methods in Clinical Trials (7 papers), Advanced Causal Inference Techniques (4 papers) and Cancer Genomics and Diagnostics (4 papers). Jared C. Foster collaborates with scholars based in United States, Canada and Netherlands. Jared C. Foster's co-authors include Jeremy M. G. Taylor, Stephen J. Ruberg, Andrew L. Himelstein, Stephen S. Grubbs, Charles L. Shapiro, Paul J. Novotny, Drew K. Seisler, James Khatcheressian, Charles L. Loprinzi and Rui Qin and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Blood.

In The Last Decade

Jared C. Foster

25 papers receiving 912 citations

Peers

Jared C. Foster

ONCOL

PRM

RNMI

Ruitao Lin United States

Donna R. Rivera United States

Brandon Arnieri United States

Jianchang Lin United States

Talal Hilal United States

Kevin J. Carroll United Kingdom

Melisa Tucker United States

Joseph C. Del Paggio Canada

Érick Moyneur United States

Anthony J. Hatswell United Kingdom

Ruitao Lin United States

Jared C. Foster

151 ×0.4

ONCOL

558 ×1.7

64 ×0.5

PRM

173 ×1.5

75 ×0.7

RNMI

Citations per year, relative to Jared C. Foster Jared C. Foster (= 1×) peers Ruitao Lin

Countries citing papers authored by Jared C. Foster

Since Specialization

Citations

This map shows the geographic impact of Jared C. Foster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jared C. Foster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jared C. Foster more than expected).

Fields of papers citing papers by Jared C. Foster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jared C. Foster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jared C. Foster. The network helps show where Jared C. Foster may publish in the future.

Co-authorship network of co-authors of Jared C. Foster

This figure shows the co-authorship network connecting the top 25 collaborators of Jared C. Foster. A scholar is included among the top collaborators of Jared C. Foster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jared C. Foster. Jared C. Foster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shin, Sarah J., Geraldine O’Sullivan Coyne, Elizabeth K. Lee, et al.. (2023). Abstract B037: A pharmacodynamic pilot study of DS8201a in patients with HER2 expressing advanced solid tumors. Molecular Cancer Therapeutics. 22(12_Supplement). B037–B037.

Salkeni, Mohamad A., Brian Ko, Brian A. Van Tine, et al.. (2023). A phase 2 study of an anti–PD-L1 antibody (atezolizumab) in dedifferentiated chondrosarcoma.. Journal of Clinical Oncology. 41(16_suppl). 11533–11533. 1 indexed citations

Foster, Jared C., Edward L. Korn, Boris Freidlin, & Jeffrey A. Moscow. (2023). The potential to backfill in phase I trials: the National Cancer Institute’s Cancer Therapy Evaluation Program experience. JNCI Cancer Spectrum. 7(6). 2 indexed citations

Sharon, Elad & Jared C. Foster. (2023). Design of phase II oncology trials evaluating combinations of experimental agents. JNCI Journal of the National Cancer Institute. 115(6). 613–618. 1 indexed citations

Foster, Jared C., Boris Freidlin, Edward L. Korn, & Malcolm A. Smith. (2020). Evaluation of the contribution of randomised cancer clinical trials evaluating agents without documented single-agent activity. ESMO Open. 5(5). e000871–e000871. 1 indexed citations

Reuss, Joshua E., Jared C. Foster, Ramya Ramaswami, et al.. (2020). Assessment of Cancer Therapy Evaluation Program Advocacy and Inclusion Rates of People Living With HIV in Anti–PD1/PDL1 Clinical Trials. JAMA Network Open. 3(12). e2027110–e2027110. 16 indexed citations

Foster, Jared C., Boris Freidlin, Charles A. Kunos, & Edward L. Korn. (2019). Single-Arm Phase II Trials of Combination Therapies: A Review of the CTEP Experience 2008–2017. JNCI Journal of the National Cancer Institute. 112(2). 128–135. 7 indexed citations

Foster, Jared C., Drew K. Seisler, Jacqueline M. Lafky, et al.. (2018). Frequency and impact of grade three or four toxicities of novel agents on outcomes of older patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma (alliance A151611). Journal of Geriatric Oncology. 9(4). 321–328. 4 indexed citations

Foster, Jared C., Jennifer Le‐Rademacher, Josephine Feliciano, et al.. (2017). Comparative “nocebo effects” in older patients enrolled in cancer therapeutic trials: Observations from a 446‐patient cohort. Cancer. 123(21). 4193–4198. 5 indexed citations

10.

Shapiro, Charles L., James P. Moriarty, Stacie B. Dusetzina, et al.. (2017). Cost-Effectiveness Analysis of Monthly Zoledronic Acid, Zoledronic Acid Every 3 Months, and Monthly Denosumab in Women With Breast Cancer and Skeletal Metastases: CALGB 70604 (Alliance). Journal of Clinical Oncology. 35(35). 3949–3955. 49 indexed citations

11.

Foster, Jared C., Drew K. Seisler, Jacqueline M. Lafky, et al.. (2016). Toxicities and Related Outcomes of Elderly Patients (pts) (≥65 Years) with Hematologic Malignancies in the Contemporary Era (Alliance A151611). Blood. 128(22). 536–536.

12.

Freedman, Rachel A., Drew K. Seisler, Jared C. Foster, et al.. (2016). Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511). Breast Cancer Research and Treatment. 161(2). 363–373. 10 indexed citations

13.

Foster, Jared C., Danping Liu, Paul S. Albert, & Aiyi Liu. (2016). Identifying Subgroups of Enhanced Predictive Accuracy from Longitudinal Biomarker Data by Using Tree-Based Approaches: Applications to Fetal Growth. Journal of the Royal Statistical Society Series A (Statistics in Society). 180(1). 247–261. 5 indexed citations

14.

Foster, Jared C., Bin Nan, Lei Shen, Niko Kaciroti, & Jeremy M. G. Taylor. (2015). Permutation Testing for Treatment–Covariate Interactions and Subgroup Identification. Statistics in Biosciences. 8(1). 77–98. 11 indexed citations

15.

Foster, Jared C., Jeremy M. G. Taylor, Niko Kaciroti, & Bin Nan. (2014). Simple subgroup approximations to optimal treatment regimes from randomized clinical trial data. Biostatistics. 16(2). 368–382. 15 indexed citations

16.

Foster, Jared C.. (2013). Subgroup Identification and Variable Selection from Randomized Clinical Trial Data.. Deep Blue (University of Michigan). 1 indexed citations

17.

Mason, Heidi, et al.. (2013). Outcomes Evaluation of a Weekly Nurse Practitioner-Managed Symptom Management Clinic for Patients With Head and Neck Cancer Treated With Chemoradiotherapy. Oncology nursing forum. 40(6). 581–586. 48 indexed citations

18.

Foster, Jared C., Jeremy M. G. Taylor, & Bin Nan. (2013). Variable selection in monotone single‐index models via the adaptive LASSO. Statistics in Medicine. 32(22). 3944–3954. 15 indexed citations

19.

Foster, Jared C., Jeremy M. G. Taylor, & Stephen J. Ruberg. (2011). Subgroup identification from randomized clinical trial data. Statistics in Medicine. 30(24). 2867–2880. 370 indexed citations

20.

Zhang, Jingsong, Jungwha Lee, Susan G. Urba, Jared C. Foster, & Francis P. Worden. (2010). A Phase II Trial Evaluating Weekly Docetaxel and Capecitabine in Patients with Metastatic or Advanced, Locally Recurrent Head and Neck Cancers. Cancer Investigation. 28(9). 910–916. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact